Post by Kamal Amzan, Dr

I spoke at the Institut Jantung Negara Malaysia (National Heart Institute, Malaysia), to a room of clinicians, management teams, and future leaders. We spoke not just about leadership, but about direction: where healthcare in Malaysia is heading if we continue to confuse cost with value, speed with progress, and performative transparency with real accountability (has the “transparent” drug pricing actually brought down bill sizes, anyone?) :) Our system cannot endure if we keep driving costs down while expecting standards to remain untouched. The math doesn’t hold, and neither does the moral logic. We should be investing upstream in prevention, into local medical and surgical supplies industry, and a national procurement agency to negotiate supply prices down. As Malaysia prepares to implement DRGs, the hope is that it doesn’t stop there YB Datuk Seri Dr Dzulkefly Ahmad - that Malaysia continues to evolve towards value-based care, where outcomes, not costs, define success. This shift demands courage: to measure, reward, and, above all, to think differently. For doctors wanting to step into management roles today, know this - you inherit a heavier brief. You are not only custodians of patients, but of principles: stewardship, equity, sustainability. Leadership, in this sense, isn’t about climbing higher. It’s about seeing further. My thanks to Datuk Seri Dr. Mohamed Ezani Md Taib, CEO of IJN Holdings, and Datuk Seri Chen Chaw Min, Chairman of IJN Holdings, for the kind invitation and for continuing to nurture thoughtful dialogue between medicine and management. Here’s to building that clarity, and a dignified Malaysia, together. Dr Kamal Amzan #CareForGood cc Ministry Of Health, Malaysia (KKM)